These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25314963)

  • 1. Timing (and biology) are everything.
    Fine HA
    Neuro Oncol; 2014 Nov; 16(11):1431-2. PubMed ID: 25314963
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients.
    Gaviani P; Salmaggi A; Silvani A
    J Neurooncol; 2011 Sep; 104(2):617-8. PubMed ID: 21229293
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.
    Rahman R; Hempfling K; Norden AD; Reardon DA; Nayak L; Rinne ML; Beroukhim R; Doherty L; Ruland S; Rai A; Rifenburg J; LaFrankie D; Alexander BM; Huang RY; Wen PY; Lee EQ
    Neuro Oncol; 2014 Nov; 16(11):1523-9. PubMed ID: 24958095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of chemotherapy for malignant brain tumors].
    Takeshima H; Kuratsu J
    No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for vascular endothelial growth factor receptor 2 inhibitors in glioblastoma?
    Chamberlain MC
    J Clin Oncol; 2014 Jul; 32(21):2272. PubMed ID: 24934790
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to M.C. Chamberlain.
    Batchelor TT; van den Bent MJ
    J Clin Oncol; 2014 Jul; 32(21):2273-4. PubMed ID: 24934784
    [No Abstract]   [Full Text] [Related]  

  • 7. Avastin: more questions than answers. .
    Desjardins A; Sampson JH
    J Neurosurg; 2012 Feb; 116(2):336-40; discussion 340. PubMed ID: 22035270
    [No Abstract]   [Full Text] [Related]  

  • 8. Bevacizumab plus irinotecan in recurrent glioblastoma.
    Chamberlain MC
    J Clin Oncol; 2008 Feb; 26(6):1012-3; author reply 1013. PubMed ID: 18281677
    [No Abstract]   [Full Text] [Related]  

  • 9. Histone deacetylase inhibitors in multiple myeloma.
    Pratt G
    Lancet Oncol; 2013 Oct; 14(11):1038-1039. PubMed ID: 24055413
    [No Abstract]   [Full Text] [Related]  

  • 10. Role for cytotoxic chemotherapy in patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
    Chamberlain MC
    Expert Rev Neurother; 2012 Aug; 12(8):929-36. PubMed ID: 23002937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New hope for relapsed and refractory multiple myeloma.
    Leleu X
    Lancet Oncol; 2013 Oct; 14(11):1028-1029. PubMed ID: 24007745
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.
    Tonder M; Eisele G; Weiss T; Hofer S; Seystahl K; Valavanis A; Stupp R; Weller M; Roth P
    Acta Oncol; 2014 Oct; 53(10):1436-40. PubMed ID: 24862539
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a role for bortezomib combinations in the management of patients with follicular lymphoma?
    Salles G
    J Clin Oncol; 2011 Sep; 29(25):3349-50. PubMed ID: 21810690
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.
    Kilickap S; Oztoprak I; Yucel B
    Acta Oncol; 2012 Apr; 51(4):544-6. PubMed ID: 22201408
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of patients with relapsed/refractory metastatic colorectal cancer.
    Grothey A
    Clin Adv Hematol Oncol; 2019 Mar; 17 Suppl 7(3):14-16. PubMed ID: 31730591
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of Relapsed and Refractory Hodgkin Lymphoma in 2018.
    Rutherford SC; Leonard JP
    JAMA Oncol; 2018 Aug; 4(8):1120-1121. PubMed ID: 30003234
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Hundsberger T; Weller M
    Praxis (Bern 1994); 2017 Apr; 106(8):415-420. PubMed ID: 28401779
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
    Kapp JP; Vance R
    J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.
    Iwamoto FM; Abrey LE; Beal K; Gutin PH; Rosenblum MK; Reuter VE; DeAngelis LM; Lassman AB
    Neurology; 2009 Oct; 73(15):1200-6. PubMed ID: 19822869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
    J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.